Microparticles: biomarkers and beyond

Dylan Burger1, Sarah Schock, Charlie S Thompson

  • 1Kidney Research Centre, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Canada. dburger@uottawa.ca

Insights

Membrane microparticles, shed from stressed cells, act as biomarkers and mediators in diseases like diabetes and hypertension. This review explores their role in pathology and detection methods.

Area of Science:

  • Cellular Biology
  • Biochemistry
  • Pathology

Background:

  • Membrane microparticles are extracellular vesicles released from stressed or injured cells.
  • Distinct from exosomes, microparticles vary in size, content, and formation.
  • Elevated microparticle levels are observed in various diseases, including diabetes and hypertension.

Purpose of the Study:

  • To review evidence of microparticles as biomarkers and mediators of disease progression.
  • To examine novel concepts in microparticle formation and biological effects.
  • To summarize current approaches for microparticle detection.

Main Methods:

  • Literature review of studies on microparticles in health and disease.
  • Analysis of research on microparticle formation and biological functions.
  • Summary of detection methodologies for microparticles.

Main Results:

  • Microparticles are found in healthy individuals and altered in disease states.
  • They are implicated as biomarkers for vascular injury and pro-thrombotic/inflammatory conditions.
  • Emerging evidence suggests microparticles actively contribute to pathological processes.

Conclusions:

  • Microparticles serve dual roles as both markers and mediators of disease.
  • Understanding microparticles is crucial for diagnosing and potentially treating various pathologies.
  • Further research into their formation and effects can reveal new therapeutic targets.